Yogesh Preet Singh

Yogesh Preet Singh

Auto-generated profile, based on publicly available information

Yogesh Preet Singh

All India Institute of Medical Sciences

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
HMHafis Muhammed
Hafis Muhammed
AJAvinash Jain
Avinash Jain
MIMohammad Irfan
Mohammad Irfan
SCSheba Charles
Sheba Charles
PDPreksha Dwivedi
Preksha Dwivedi
FIFor The Sle-Sig Of Ira
For The Sle-Sig Of Ira

13 April 2022 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
YSYogesh Preet Singh
Yogesh Preet Singh
DRDebaditya Roy
Debaditya Roy
BJBhargavi Jois
Bhargavi Jois
MSMohit Shetti
Mohit Shetti
A man in his 60s developed reactive arthritis following treatment with intravesical Bacillus Calmette-Guerin (iBCG) for papillary carcinoma of bladder. Evaluation revealed leucocytosis and raised inflammatory markers. HLA B27 was positive. Based on the temporal relationship, it was attributed to BCG-related reactive arthritis. iBCG was stopped. Treatment with non-steroidal anti-inflammatory drugs (NSAIDS) and glucocorticoids were ineffective. Prolonged course of disease-modifying antirheumatic drugs (DMARDS) was required which aided in alleviation of symptoms and sustained remission. Intravesical BCG therapy is a treatment for bladder cancer. It is rarely associated with reactive arthritis, which responds to discontinuation of iBCG and treatment with NSAIDS and/or short-term glucocorticoids. iBCG-related reactive arthritis commonly has an acute/subacute course. Chronic arthritis as observed in our case requiring prolonged treatment with DMARDS is rare.

25 October 2022
Verified
Closed access
MDMrinalini Dey
Mrinalini Dey
RNR Naveen
R Naveen
Elena NikiphorouElena Nikiphorou
Elena Nikiphorou
PSParikshit Sen
Parikshit Sen
SSSreoshy Saha
Sreoshy Saha
MGMargarita Aleksandrovna Gromova
Margarita Aleksandrovna Gromova


10 October 2025 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
RGRudra P. Goswami
Rudra P. Goswami
PSParikshit Sen
Parikshit Sen
ZFZoha Zahid Fazal
Zoha Zahid Fazal
JPJasmine Parihar
Jasmine Parihar
YSYogesh Preet Singh
Yogesh Preet Singh
LGLatika Gupta
Latika Gupta

9 September 2024 in Indian Journal of Rheumatology
Verified
Journal Article
Open access
YSYogesh Preet Singh
Yogesh Preet Singh
SBSukhdeep Bains
Sukhdeep Bains
NJNaman Jain
Naman Jain
Vasculitis is a group of heterogeneous conditions characterised by inflammation of blood vessels. Based on the predominant size of the affected vessel, vasculitis is classified into small, medium, and large vessel vasculitis (LVV). Giant cell arteritis (GCA) and Takayasu’s arteritis (TAK) are the two major types of LVV. GCA was thought to affect only the external carotid artery and its branches, whereas, TAK was thought to affect the aorta and its major branches. Advances in imaging techniques have led to a better understanding of these conditions. It has become increasingly clear that GCA can involve the aorta and its branches. GCA and TAK have overlapping features like propensity to affect the aorta and its branches, similar histopathology, and similar clinical features. However, there are differences in age, geographic location, genetics, and predominant vascular territory involvement. There are subtle differences in clinical features. Are these conditions different ends of the same spectrum or different conditions with similar features? This review compares and contrasts these two conditions based on epidemiology, genetics, pathology, predominant vascular territory involvement, and any differential response to treatment. Based on current evidence, GCA and TAK seem to be distinct conditions and not different ends of the same spectrum.